ZIVO BioscienceNASDAQ: ZIVO

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

ZIVO Bioscience is in the Healthcare sector

ZIVO Bioscience is in the Biotechnology industry

ZIVO Bioscience is headquartered in United States

ZIVO Bioscience initial public offering (IPO) was on 15 December 2003

https://www.zivobioscience.com

No, ZIVO Bioscience is not included in the S&P 500 index

No, ZIVO Bioscience is not included in the NASDAQ 100 index

No, ZIVO Bioscience is not included in the Dow Jones index

No data